Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Learn about the flu shot, COVID-19 vaccine, and our masking policy »
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
A placebo-controlled trial of venlafaxine XR in patients with recurrent unipolar major depression to assess recurrence prevention 25th Congress of the Collegium-Internationale-Neuro-Psychopharmacologicum (CINP)/29th Annual Meeting of the Canadian-College-of-Neuropsychopharmacology Keller, M., Yan, B., Dunner, D., Ferguson, J., FRIEDMAN, E., Gelenberg, A., Hirschfeld, R., Kocsis, J., Kornstein, S., Nemeroff, C., Ninan, P., Rothschild, A., Schatzberg, A., Shelton, R., Thase, M., Trivedi, M., Zajecka, J., Ahmed, S., Musgnung, J., Parker-Zavod, E., Pedersen, R. CAMBRIDGE UNIV PRESS. 2006: S233–S233
View details for Web of Science ID 000239495501306